Download this application note to learn more about targeted sequencing approaches such as RNA exome sequencing. Is the form ...
For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...
TheFly reported on April 10 that Piper Sandler began coverage of CAI with a Neutral rating and a $21 price target.
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Increasing prevalence of bleeding disorders, rising number of surgical procedures, aging population, and growing focus on interoperability are the major factors which drive global market growth.WILMIN ...
According to a new report published by Allied Market Research, the global Genomics Services Market was valued at $8.3 billion ...
Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...
A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.
(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
12d
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results